StageIPO | IPO
Date of IPO7/22/2021
Zevia manufactures sugar free, stevia sweetened, natural diet soda. The brand is on a mission to provide soft drink lovers a smarter soda option containing no sugar and no artificial sweeteners.
Missing: Zevia's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Zevia's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Expert Collections containing Zevia
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Zevia is included in 2 Expert Collections, including Food & Beverage .
Food & Beverage
We define wellness tech as companies developing technology to help consumers improve their physical, mental, and social well-being. Companies in this collection play across a wide range of categories, including food and beverage, fitness, personal care, and corporate wellness.
Latest Zevia News
May 9, 2023
05/09/2023 | 07:12am EDT Message : Q1 Gross Margin of 46.4%, up 4.7% year-over-year and 2.1% sequentially Zevia PBC (“Zevia” or the “Company”) (NYSE: ZVIA), the company disrupting the liquid refreshment beverage industry with great tasting, zero sugar beverages made with simple, plant-based ingredients, today reported results for the first quarter ended March 31, 2023. First Quarter 2023 Highlights Unit volume decreased 2.7% year-over-year to 3.3 million equivalized cases Gross profit margin of 46.4%, the strongest gross margin percentage of any quarterly period to date as a public company Net loss was $2.9 million, including $2.4 million of non-cash equity-based compensation expense, the strongest quarter to date as a public company Adjusted EBITDA loss was $0.5 million(1), the strongest quarter to date as a public company Loss per share was $0.04 per diluted share to Zevia’s Class A common stockholders “Margin and profitability improvements were defining achievements in the first quarter, including a 470 basis point increase in gross margin compared to the same quarter last year, the strongest quarter since Zevia became a public company,” said Amy Taylor, President and Chief Executive Officer. “Our team’s sharp focus on cost management and execution were key factors impacting our progress on our path to profitability. First quarter results were aided by pricing actions last year which also helped propel net sales ahead of our expectations.” “Our first quarter results give us continued confidence in our full-year outlook, as we enter the key spring and summer beverage season from a position of strength,” Taylor continued. “Customer reaction to our brand refresh has been overwhelmingly positive and we expect the same from consumers as we begin to ramp up marketing in support of the roll-out. We remain focused on expanding our consumer base, driving trial and accelerating velocity as more consumers are buying Zevia than ever. To support this continued expansion, we plan to invest in marketing and our supply chain optimization initiatives through the remainder of 2023.” (1) Adjusted EBITDA is a non-GAAP financial measure. See the supplementary schedules in this press release for a discussion of how we define and calculate this measure and a reconciliation thereof to the most directly comparable GAAP measure. First Quarter 2023 Results Net sales increased 13.8% to $43.3 million in the first quarter of 2023 compared to $38.0 million in the first quarter of 2022. Growth in net sales was primarily driven by higher price realizations partially offset by volume and mix factors. Gross profit improved to $20.1 million for the first quarter of 2023, a 26.6% increase compared to $15.9 million in the first quarter of 2022, reflecting net sales growth partially offset by higher manufacturing costs as a result of inflationary pressures. Gross profit margin of 46.4% was up 4.7% compared to the first quarter of 2022 and up 2.1% on a sequential basis compared to the fourth quarter of 2022. The year-over-year improvement in gross profit margin was primarily due to growth in net sales driven by pricing partially offset by slightly higher manufacturing costs as a result of inflationary pressures. Selling and marketing expenses were $11.9 million, or 27.5%, of net sales in the first quarter of 2023 compared to $14.1 million, or 36.9%, of net sales in the first quarter of 2022. The decrease was primarily due to a $1.3 million reduction in freight and warehousing costs and a $0.9 million decline in non-working marketing costs. General and administrative expenses were $8.6 million, or 20.0%, of net sales in the first quarter of 2023 compared to $10.1 million, or 26.6%, of net sales in the first quarter of 2022. The decrease was primarily due to a $1.2 million decrease in public company costs due to expense optimization initiatives, and decreased headcount and personnel costs. Equity-based compensation, a non-cash expense, was $2.4 million in the first quarter of 2023, compared to $8.9 million in the first quarter of 2022. The decrease was primarily due to restricted stock units and restricted phantom stock awards that vested over six months following the Company's initial public offering in the prior year period. Net loss for the first quarter of 2023 was $2.9 million, compared to net loss of $17.5 million in the first quarter of 2022. Loss per share for the first quarter of 2023 was $0.04 per diluted share to Zevia’s Class A common stockholders, compared to loss per share of $0.28 in the first quarter of 2022. Adjusted EBITDA loss was $0.5 million in the first quarter of 2023, compared to an Adjusted EBITDA loss of $8.3 million in the first quarter of 2022. Adjusted EBITDA is a non-GAAP financial measure. See the supplementary schedules in this press release for a discussion of how we define and calculate this measure and a reconciliation thereof to the most directly comparable GAAP measure. Balance Sheet and Cash Flows As of March 31, 2023, the Company had $56.0 million in cash and cash equivalents and no outstanding debt, as well as an unused credit line of $20 million compared to $47.4 million in cash and cash equivalents, no outstanding debt, and an unused line of credit of $20 million as of December 31, 2022. As of March 31, 2023, the Company had working capital of $73.3 million. The Company spent $0.9 million on capital expenditures during the first quarter of 2023 to support its growth initiatives compared to capital expenditures of $0.6 million during the first quarter of 2022. 2023 Guidance The Company is maintaining its guidance for the full year of 2023 and continues to expect net sales to be in the range of $180 million to $190 million, an increase of 10% to 16% compared to 2022. For the second quarter of 2023, net sales are expected to be in the range of $48 million to $51 million, an increase of 5% to 12% compared to the second quarter of 2022. Webcast The Company will host a conference call today at 8:30 a.m. Eastern Time to discuss this earnings release. Investors and other interested parties may listen to the webcast of the conference call by logging on via the Investor Relations section of Zevia’s website at https://investors.zevia.com/ or directly here . A replay of the webcast will be available for approximately thirty (30) days following the call. Forward-Looking Statements This press release contains “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements include, without limitation, any statement that may predict, forecast, indicate or imply future results, performance or achievements, and may contain words such as “on track,” “guidance,” “outlook,” “believe,” “anticipate,” “expect,” “consider,” “contemplate,” “continue,” “would,” “could,’” “may,” “potential,” “estimate,” “intend,” “project,” “plan,” “seek,” “pursue,” “will,” or words or phrases with similar meaning. Forward-looking statements should not be read as a guarantee of future performance or results and will not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved. Forward-looking statements contained in this press release relate to, among other things, statements regarding 2023 Guidance and anticipated growth, strategic direction, branding, operating environment, distribution, velocity, pricing and costs. Forward-looking statements are based on current expectations, forecasts and assumptions that involve risks and uncertainties, including, but not limited to, the ability to develop and maintain our brand, our ability to successfully execute on our rebranding strategy and cost reduction initiatives, change in consumer preferences, pricing factors, the impact of inflation on our sales growth and cost structure such as increased commodity, packaging, transportation and freight, warehouse, labor and other input costs and other economic, competitive and governmental factors outside of our control, such as pandemics or epidemics, including the impact of the effects of the COVID-19 pandemic, and adverse global macroeconomic conditions, including rising interest rates, instability in financial institutions and a recessionary environment, and geopolitical events or conflicts, that may cause our business, strategy or actual results to differ materially from the forward-looking statements. We do not intend and undertake no obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required by applicable law. Investors are referred to our filings with the U.S. Securities and Exchange Commission for additional information regarding the risks and uncertainties that may cause actual results to differ materially from those expressed in any forward-looking statement. About Zevia Zevia PBC, a Delaware public benefit corporation designated as a “Certified B Corporation,” is focused on addressing the global health challenges resulting from excess sugar consumption by offering a broad portfolio of zero sugar, zero calorie, naturally sweetened beverages. All Zevia® beverages are made with a handful of simple, plant-based ingredients, contain no artificial sweeteners, and are Non-GMO Project verified, gluten-free, Kosher, vegan and zero sodium. Zevia is distributed in more than 32,000 retail locations in the U.S. and Canada through a diverse network of major retailers in the food, drug, warehouse club, mass, natural and ecommerce channels. (ZEVIA-F) Use of Non-GAAP Financial Information We use Adjusted EBITDA, a financial measure that is not calculated in accordance with U.S. generally accepted accounting principles (“GAAP”). The Company’s management believes that Adjusted EBITDA, when taken together with our financial results presented in accordance with GAAP, provides meaningful supplemental information regarding our operating performance and facilitates internal comparisons of our historical operating performance on a more consistent basis by excluding certain items that may not be indicative of our business, results of operations or outlook. In particular, we believe that the use of Adjusted EBITDA is helpful to our investors as it is a measure used by management in assessing the health of our business, determining incentive compensation and evaluating our operating performance, as well as for internal planning and forecasting purposes. We calculate Adjusted EBITDA as net income (loss) adjusted to exclude: (1) other income (expense), net, which includes interest (income) expense, foreign currency (gains) losses, and (gains) losses on disposal of fixed assets, (2) provision (benefit) for income taxes, (3) depreciation and amortization, and (4) equity-based compensation. Adjusted EBITDA may in the future also be adjusted for amounts impacting net income related to the Tax Receivable Agreement liability and other infrequent and unusual transactions. Adjusted EBITDA is presented for supplemental informational purposes only, has limitations as an analytical tool and should not be considered in isolation or as a substitute for financial information presented in accordance with GAAP. Some of the limitations of Adjusted EBITDA include that (1) it does not properly reflect capital commitments to be paid in the future, (2) although depreciation and amortization are non-cash charges, the underlying assets may need to be replaced and Adjusted EBITDA does not reflect these capital expenditures, (3) it does not consider the impact of equity-based compensation expense, including the potential dilutive impact thereof, and (4) it does not reflect other non-operating expenses, including interest (income) expense, foreign currency (gains) losses and (gains) losses on disposal of fixed assets. In addition, our use of Adjusted EBITDA may not be comparable to similarly titled measures of other companies because they may not calculate Adjusted EBITDA in the same manner, limiting its usefulness as comparative measures. Because of these limitations, when evaluating our performance, you should consider Adjusted EBITDA alongside other financial measures, including our net loss or income and other results stated in accordance with GAAP. The following table presents a reconciliation of net loss, the most directly comparable financial measure stated in accordance with GAAP, to Adjusted EBITDA for the periods presented:
Zevia Frequently Asked Questions (FAQ)
When was Zevia founded?
Zevia was founded in 2007.
Where is Zevia's headquarters?
Zevia's headquarters is located at 15821 Ventura Blvd, Encino.
What is Zevia's latest funding round?
Zevia's latest funding round is IPO.
How much did Zevia raise?
Zevia raised a total of $246.66M.
Who are the investors of Zevia?
Investors of Zevia include Caisse de depot et placement du Quebec, Paycheck Protection Program, Northwood Ventures, NGEN Partners and Paddy Spence.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.